| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BRD-K44224150 | CTRPv2 | pan-cancer | AAC | 0.49 | 2e-13 |
| mRNA | JW-480 | CTRPv2 | pan-cancer | AAC | 0.19 | 2e-07 |
| mRNA | BRD-K92856060 | CTRPv2 | pan-cancer | AAC | 0.15 | 9e-06 |
| mRNA | trifluoperazine | CTRPv2 | pan-cancer | AAC | 0.16 | 1e-05 |
| mRNA | carboplatin:UNC0638 (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.15 | 3e-05 |
| mRNA | PF-184 | CTRPv2 | pan-cancer | AAC | 0.12 | 0.0002 |
| mRNA | pifithrin-mu | CTRPv2 | pan-cancer | AAC | 0.12 | 0.0003 |
| mRNA | PRL-3 Inhibitor I | CTRPv2 | pan-cancer | AAC | 0.13 | 0.0003 |
| mRNA | SKI-II | CTRPv2 | pan-cancer | AAC | 0.13 | 0.0004 |
| mRNA | SB-525334 | CTRPv2 | pan-cancer | AAC | 0.12 | 0.0007 |